Detalhe da pesquisa
1.
Genome-wide in vivo CRISPR screen identifies TGFß3 as actionable biomarker of palbociclib resistance in triple negative breast cancer.
Mol Cancer
; 23(1): 118, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38831405
2.
Study protocol for the sheMATTERS study (iMproving cArdiovascular healTh in new moThERS): a randomized behavioral trial assessing the effect of a self-efficacy enhancing breastfeeding intervention on postpartum blood pressure and breastfeeding continuation in women with hypertensive disorders of pregnancy.
BMC Pregnancy Childbirth
; 23(1): 68, 2023 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36703104
3.
Identification of MFGE8 and KLK5/7 as mediators of breast tumorigenesis and resistance to COX-2 inhibition.
Breast Cancer Res
; 23(1): 23, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33588911
4.
Correction: Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation.
J Biol Chem
; 299(10): 105298, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37812844
5.
Concomitant Expression of Prolactin Receptor and TGFß Receptors in Breast Cancer: Association with Less Aggressive Phenotype and Favorable Patient Outcome.
Int J Mol Sci
; 20(7)2019 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30987013
6.
Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells.
Br J Cancer
; 119(12): 1495-1507, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30482914
7.
Differential expression of TGFß isoforms in breast cancer highlights different roles during breast cancer progression.
Tumour Biol
; 40(1): 1010428317748254, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29320969
8.
Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor ß/Smad signaling and associates with favorable breast cancer disease outcomes.
Breast Cancer Res
; 16(6): 476, 2014 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25499443
9.
Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs.
NPJ Precis Oncol
; 8(1): 128, 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38839871
10.
Multiple Endocrine Neoplasia Type 1 Regulates TGFß-Mediated Suppression of Tumor Formation and Metastasis in Melanoma.
Cells
; 13(11)2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38891107
11.
Cyclin D1 cooperates with p21 to regulate TGFß-mediated breast cancer cell migration and tumor local invasion.
Breast Cancer Res
; 15(3): R49, 2013 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23786849
12.
Development of buffers for fast semidry transfer of proteins.
Anal Biochem
; 441(2): 182-4, 2013 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23872007
13.
Combined in vitro/in vivo genome-wide CRISPR screens in triple negative breast cancer identify cancer stemness regulators in paclitaxel resistance.
Oncogenesis
; 12(1): 51, 2023 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932309
14.
A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFß-mediated breast cancer cell migration and invasion.
Breast Cancer Res
; 14(5): R127, 2012 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22995475
15.
Erratum to: A novel function for p21 Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFß-mediated breast cancer cell migration and invasion.
Breast Cancer Res
; 19(1): 40, 2017 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28351421
16.
Erratum to: Cyclin D1 cooperates with p21 to regulate TGFß-mediated breast cancer cell migration and tumor local invasion.
Breast Cancer Res
; 19(1): 43, 2017 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28351372
17.
Terminal differentiation and anti-tumorigenic effects of prolactin in breast cancer.
Front Endocrinol (Lausanne)
; 13: 993570, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36157462
18.
Activin/TGF-beta induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP.
Nat Cell Biol
; 4(12): 963-9, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12447389
19.
TGFß/cyclin D1/Smad-mediated inhibition of BMP4 promotes breast cancer stem cell self-renewal activity.
Oncogenesis
; 10(3): 21, 2021 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33649296
20.
Prolactin receptor-driven combined luminal and epithelial differentiation in breast cancer restricts plasticity, stemness, tumorigenesis and metastasis.
Oncogenesis
; 10(1): 10, 2021 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33446633